Roivant Sciences (ROIV) Inventory (2023 - 2024)
Roivant Sciences (ROIV) reported Inventory of $34.0 million for Q2 2024, up 704.66% on a YoY basis from $4.2 million in Q3 2023, and down 3.56% quarter-over-quarter from $35.3 million in Q1 2024.
Roivant Sciences (ROIV) Inventory (2023 - 2024) Analysis & Trends
Roivant Sciences has reported Inventory for 2 years, with the latest figure at $34.0 million in Q2 2024.
- For the quarter ending Q2 2024, Inventory rose 704.66% year-over-year to $34.0 million; the trailing twelve-month figure through Jun 2024 stood at $34.0 million (up 704.66% YoY), and the FY2024 full-year result was $35.3 million, up 1176.75% from the prior year.
- Inventory for Q2 2024 stood at $34.0 million, down from $35.3 million in the prior quarter.
- The five-year high for Inventory was $35.3 million in Q1 2024, with the low at $2.8 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 34.00 Mn |
| Mar 31, 2024 | 35.25 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Sep 30, 2023 | 4.91 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 2.76 Mn |